Clinical trial
The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial
NCT00468533 · Yu-Li Hospital, Other · Unknown status
Key facts
| NCT number | NCT00468533 |
|---|---|
| Title | The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial |
| Official title | The Monitor of Serum Prolactin Level and Related Clinical Observations Among Individuals With Schizophrenia Spectrum Illnesses in a 3 Months Aripiprazole Trial |
| Lead sponsor | Yu-Li Hospital, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Tardive Dyskinesia, Metabolic Syndrome |
| Intervention type | Drug |
| Interventions | Aripiprazole |
| Enrollment | 50 |
| Start date | May 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | May 2, 2007 |
| Last update posted | May 2, 2007 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: